Doxazosin for Psychostimulant Dependence

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Methamphetamine or Cocaine Dependence
Interventions
DRUG

Doxazosin extended release

initially maintained on doxazosin extended release 4 mg once a day for 7 days, then the dose is increased to 8 mg once per day for the duration of the trial.

Trial Locations (1)

72205

UAMS Psychiatric Research Institute, Little Rock

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Baylor College of Medicine

OTHER

lead

University of Arkansas

OTHER

NCT01371851 - Doxazosin for Psychostimulant Dependence | Biotech Hunter | Biotech Hunter